{
    "pmcid": "11722225",
    "qa_pairs": {
        "How do mosaic-8b RBD-nanoparticles aim to maintain neutralization potency against variants like KP.3 and JN.1?": [
            "By directing the immune response towards conserved RBD epitopes.",
            "By increasing the overall size of the nanoparticles to enhance immune activation.",
            "By incorporating additional adjuvants to boost immune response.",
            "By focusing on non-RBD regions of the spike protein."
        ],
        "What is the main reason for the reduced efficacy of the FDA-approved mAb Pemgarda against certain variants?": [
            "Mutations in the RBD of variants like KP.3.1.1 alter key epitopes targeted by Pemgarda.",
            "Pemgarda is designed to target non-conserved regions of the spike protein.",
            "Pemgarda is only effective against the original strain of SARS-CoV-2.",
            "Pemgarda has a short half-life, reducing its efficacy over time."
        ],
        "What is the primary goal of using mosaic-8b RBD-nanoparticles in the study?": [
            "To elicit antibodies targeting conserved RBD regions across multiple sarbecoviruses.",
            "To enhance the binding affinity of antibodies to a single SARS-CoV-2 variant.",
            "To increase the production of antibodies specific to the KP.3 variant.",
            "To develop antibodies that only target zoonotic sarbecoviruses."
        ],
        "What method was used to demonstrate the broad neutralization capabilities of antibodies elicited by mosaic-8b RBD-nanoparticles?": [
            "Deep mutational scanning, in vitro selection, and structural analysis.",
            "Clinical trials involving human subjects.",
            "Animal studies using mice and ferrets.",
            "Computational modeling and simulations."
        ],
        "Which SARS-CoV-2 variants are specifically mentioned as posing challenges for existing therapeutic mAbs?": [
            "KP.3 and JN.1",
            "Alpha and Delta",
            "Beta and Gamma",
            "Omicron and Lambda"
        ]
    }
}